Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|November 14, 2024
Inebilizumab for Treatment of IgG4-Related DiseaseJohn H Stone, Arezou Khosroshahi, Wen Zhang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2019
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related DiseaseZachary S Wallace, Ray P Naden, Suresh Chari, et al.
Arthritis Care & Research|February 20, 2018
An International Multispecialty Validation Study of the IgG4-Related Disease Responder IndexZachary S Wallace, Arezou Khosroshahi, Mollie D Carruthers, et al.
The Journal of Allergy and Clinical Immunology|June 3, 2020
CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related diseaseCory A Perugino, Naoki Kaneko, Takashi Maehara, et al.
Panminerva Medica|April 16, 2021
Outcomes of noninvasive ventilation as the ceiling of treatment in patients with COVID-19Giuseppe A Ramirez, Enrica P Bozzolo, Agnese Gobbi, et al.
The New England Journal of Medicine|June 3, 2026
Obexelimab for the Treatment of IgG4-Related DiseaseEmanuel Della-Torre, Matthew C Baker, Wen Zhang, et al.
The Lancet. Rheumatology|November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases frameworkEmanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
United European Gastroenterology Journal|June 20, 2020
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendationsJ-Matthias Löhr, Ulrich Beuers, Miroslav Vujasinovic, et al.
Clinical and Experimental Rheumatology|March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody productsRosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2025
Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction ModelMarco Lanzillotta, Peter Macinga, Jakob L Poulsen, et al.
Pageof 10